An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 328-332

  Prantera, C ^a,b   Zannoni, F ^a   Scribano, Maria Lia ^a   Berto, Eva ^a   Andreoli, A ^a   Kohn, Anna ^a   Luzi, C ^a  

^a Ospedale Regina Margherita   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; METHYLPREDNISOLONE; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEARTBURN; HUMAN; HYPERAMYLASEMIA; INTESTINE FLORA; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CIPROFLOXACIN; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; METRONIDAZOLE; MIDDLE AGED; PATIENT COMPLIANCE; TIME FACTORS;

EID: 0030065270     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Moss AA, Carbone JV, Kressel HY. Radiological and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. AJR 1978;131:787-90.
2. Keighley MRB. Infection and the use of antibiotics in Crohn's disease. Can J Surg 1984;27:438-41.
3. Rutgeerts P, Geboes K, Peeters M, et al. Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
4. Keighley MRB, Arabi Y, Dimock F, et al. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978;19:1099-104.
5. Ambrose NS, Youngs D, Burdon DW, et al. Changes in intestinal microflora in Crohn's disease. Br J Surg 1982;69:681.
6. Aluwihare AP. Electron microscopy in Crohn's disease. Gut 1971;12: 509-18.
7. Ambrose NS, Johnson M, Burdon DW, et al. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg 1984;71:623-5.
8. Gitnick G. Antibiotics and inflammatory bowel diseases. In: Ginsberg AL, ed. Gastroenterology clinics of North America. Philadelphia: WB Saunders Co. 1989;18:51-6.
9. Elliott PR, Burnham WR, Berghouse LM, et al. Sulphadoxine-pyrimethamine therapy in Crohn's disease. Digestion 1982;23:132-4.
10. Ursing B, Alm T, Barany F, et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology 1982; 83:550-62.
11. Ambrose NS, Allan RN, Keighley MRB, et al. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. Dis Colon Rectum 1985;28:81-5.
12. Saverymuttu S, Hodgson HJF, Chadwick VS. Controlled trial comparing prednisolone with an elemental diet plus nonabsorbable antibiotics in active Crohn's disease. Gut 1985;26:994-8.
13. Sutherland L, Singleton J, Sessions J, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32: 1071-5.
14. Ursing B, Kamme G. Metronidazole for Crohn's disease. Lancet 1975;1:775-7.
15. Gilat T. Metronidazole in Crohn's disease. Gastroenterology 1982;83: 702-4.
16. Hakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984;79:533-40.
17. Bernstein LH, Frank MS, Brandt LJ, et al. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980;79:357-65.
18. Sanders CC, Sanders WE, Goerging RV. Overview of preclinical studies with ciprofloxacin. Am J Med 1987;82:2-11.
19. Norel CE. Effect of new quinolones on the human gastrointestinal microflora. Rev Infect Dis 1988;10(suppl 1):5193-6.
20. Turunen U, Farkkila M, Valtonen V, et al. Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease. Gastroenterology (Suppl), 1993;104: A793.
21. Peppercorn MA. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastroenterol 1993;17:235-7.
22. Prantera C, Kohn A, Zannoni F, et al. Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: Results of an open study. J Clin Gastroenterol 1994;19:79-88.
23. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979;77:847-69.
24. Malchow H, Ewe J, Brandes W, et al. European Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1984;86: 249-66.
25. Singleton JW, Law DH, Kelley L, et al. National Cooperative Crohn's Disease Study: Adverse reactions to study drugs. Gastroenterology 1979;77:870-82.
26. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
27. Wolf J. Ciprofloxacin may be useful in Crohn's disease. Gastroenterology 1990;98:A212.
28. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Gastroenterology 1985;88:1818-25.
29. Prantera C, Kohn A, Mangiarotti R, et al. Antimycobacterial therapy in Crohn's disease: Results of a controlled double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 1994;89:513-8.
30. Miller JJ. The imidazoles as immunosuppressive agents. Transplant Proc 1980;12:300-3.